Iovance Biotherapeutics
The MSAT Specialist at Iovance Biotherapeutics is a subject matter expert in cell therapy manufacturing operations, responsible for data analysis, deviation investigations, technology transfer, and documentation authoring. The role supports cross‑functional teams, provides on‑site manufacturing oversight, and conducts laboratory activities to ensure GMP compliance and process excellence.
Headquarters
San Carlos, California, United States
Company Size
501-1000 employees
Founded
2007
Iovance Biotherapeutics is a clinical-stage biopharmaceutical company developing tumor-infiltrating lymphocyte (TIL) therapies for solid tumors. Its lead product Amtagvi (lifileucel) is being investigated in multiple clinical trials, with manufacturing conducted at the Iovance Cell Therapy Center in Philadelphia, PA, and collaborations with academic and industry partners to advance next-generation TIL platforms.
Iovance Biotherapeutics’ Latest Moves Shape Market Outlook
7 hours ago
A Look At Iovance Biotherapeutics (IOVA) Valuation After Sharp Recent Share Price Momentum
3 days ago
Iovance Biotherapeutics: The High‑Risk Cancer Stock I Think Could Change a Portfolio by 2036
1 week ago
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Iovance Biotherapeutics.
Iovance Biotherapeutics didn’t post a salary, so this is our estimate from similar listings.
17% above the average for this role
Iovance Biotherapeutics: Short-Term Pain, Long-Term Gain - I'm Still Bullish After All These Years
1 week ago